V Rossii zaregistrirovan Ksalkori®(krizotinib) kak pervyy i edinstvennyypreparat dlya lecheniya ALK-pozitivnogonemelkokletochnogo raka legkogo
- 作者: - -
- 期: 卷 14, 编号 4 (2012)
- 页面: 7-
- 栏目: Articles
- URL: https://journals.rcsi.science/1815-1434/article/view/29516
- ID: 29516
如何引用文章